J. Yordy

发表

Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms.

David P Turner, V. Findlay, A. Larue, 2011, Genes & cancer.

Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.

J. Weinstein, K. Coombes, G. Mills, 2012, Cancer discovery.

SP100 inhibits ETS1 activity in primary endothelial cells

D. Chaussabel, Runzhao Li, D. Watson, 2005, Oncogene.

miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer1

J. Heymach, M. Story, L. Ding, 2019, Neoplasia.

SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion

V. Sementchenko, Runzhao Li, R. Muise-Helmericks, 2004, Oncogene.

EAPII interacts with ETS1 and modulates its transcriptional function

Runzhao Li, D. Watson, Q. Leng, 2003, Oncogene.

Evaluation of the Response of HNSCC Cell Lines to γ-Rays and 12C Ions: Can Radioresistant Tumors Be Identified and Selected for 12C Ion Radiotherapy?

A. Davis, A. Pompoš, M. Story, 2022, Frontiers in Oncology.

NQO1 bioactivatable drugs enhance radiation responses

Jinming Gao, D. Boothman, R. Brekken, 2016 .

miR-551a and miR-551b-3p target GLIPR2 and promote tumor growth in High-Risk Head and Neck Cancer by modulating autophagy

M. Story, L. Ding, D. Vo, 2015, bioRxiv.

Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer.

Olivier Lichtarge, Marek Kimmel, Beth M Beadle, 2015, Cancer research.

NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer

Xian-Jin Xie, Longshan Li, D. Boothman, 2016, Molecular Cancer Therapeutics.

Signal transduction and the Ets family of transcription factors

R. Muise-Helmericks, J. Yordy, 2000, Oncogene.

TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence

K. Ang, R. Meyn, J. Myers, 2011, Clinical Cancer Research.

Role of 53BP1 in the Regulation of DNA Double-Strand Break Repair Pathway Choice

T. Pandita, C. Hunt, N. Horikoshi, 2014, Radiation research.

Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.

Michael Peyton, Li Shen, John N Weinstein, 2012, Cancer discovery.

Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers.

Melissa C. Srougi, Wareef Kabbani, Longshan Li, 2014, Antioxidants & redox signaling.

NQO 1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer

Xian-Jin Xie, Longshan Li, D. Boothman, 2016 .

Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer.

T. Solberg, R. Timmerman, L. Nedzi, 2017, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Targeted inhibition of histone deacetylases and hedgehog signaling suppress tumor growth and homologous recombination in aerodigestive cancers.

T. Pandita, N. Horikoshi, R. Pandita, 2015, American journal of cancer research.

Predictive Biomarkers and Personalized Medicine TP 53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence

K. Ang, R. Meyn, J. Myers, 2011 .

DNA Repair Biomarker Profiling of Head and Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death following Radiotherapy

A. Garden, K. Ang, R. Weber, 2011, Clinical Cancer Research.

A Retrospective Analysis of Tumor Volumetric Responses to Five-Fraction Stereotactic Radiotherapy for Paragangliomas of the Head and Neck (Glomus Tumors)

R. Timmerman, K. Choe, L. Nedzi, 2014, Stereotactic and Functional Neurosurgery.

Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.

Jeffrey E. Lee, R. Wolff, J. Fleming, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Isolated central nervous system progression on Crizotinib

P. Iyengar, R. Timmerman, K. Choe, 2012, Cancer biology & therapy.

Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer.

D. Sinha, D. Watson, P. Halushka, 2005, Cancer research.

Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer.

D. Sinha, D. Watson, P. Halushka, 2005, Cancer research.

Predictive Biomarkers and Personalized Medicine DNA Repair Biomarker Profiling of Head and Neck Cancer : Ku 80 Expression Predicts Locoregional Failure and Death following Radiotherapy

A. Garden, K. Ang, R. Weber, 2011 .

A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck

H. Choy, Yang Xie, L. Nedzi, 2017, Cancer investigation.

Wavelet Analysis in Current Cancer Genome Research: A Survey

Shu-Ching Chen, Mei-Ling Shyu, Yimin Yang, 2013, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

Commissioning and initial stereotactic ablative radiotherapy experience with Vero

Chuxiong Ding, John Yordy, Timothy D. Solberg, 2014, Journal of applied clinical medical physics.

A contour-guided deformable image registration algorithm for adaptive radiotherapy

Steve B. Jiang, Xun Jia, Steve B Jiang, 2011, Physics in medicine and biology.

Automated landmark-guided deformable image registration

Xuejun Gu, Jing Wang, Weihua Mao, 2015, Physics in medicine and biology.